Find Your Next Crypto, AI or Fintech role
JobStash is a job board which empowers the data and analytics demanding user to make an informed decision about which role to choose for their future career in crypto, AI, robotics or fintech.
Or explore by
JobStash is a job board which empowers the data and analytics demanding user to make an informed decision about which role to choose for their future career in crypto, AI, robotics or fintech.
Replit·1 week ago
Replit is an agentic AI software-creation platform for creating, launching, and growing apps, websites, tools, and businesses through natural language.
Funding
Investors
Arena is a community-powered AI evaluation platform where people compare frontier-model outputs and vote, generating human-preference data and public leaderboards.
Investors
Waymo is an Alphabet company operating a public, fully autonomous ride-hailing service and developing the AI-powered Waymo Driver autonomous-driving system.
Funding
Investors
Hebbia·2 weeks ago
Hebbia is an AI platform for institutional finance that lets teams use AI agents to research, analyze, and produce work across complex document and data sets.
Periodic Labs·2 weeks ago
AI research and deployment company building AI scientists and autonomous laboratories for physical-science discovery.
Funding
Ambience Healthcare provides an AI platform for clinical documentation, coding, revenue integrity, and clinical workflows for health systems.
Krea·3 weeks ago
Krea is an active generative-AI creative platform for generating, editing, and enhancing images, video, and 3D content.
Descript·3 weeks ago
Descript is an active AI video and audio editing company whose editor lets users create, edit, and share media through text-based and AI-assisted workflows.
Funding
Investors
OpenAI·3 weeks ago
AI research and deployment company building and deploying frontier AI products, including ChatGPT, Codex, and its API platform.
Funding
Investors
Genesis Molecular AI·3 weeks ago
AI-focused biotechnology company developing molecular-AI systems and small-molecule drug candidates for internal programs and pharmaceutical partners.